Lantern Pharma (LTRN) Cash & Equivalents (2019 - 2026)
Lantern Pharma (LTRN) posted Cash & Equivalents of $6.66 million for Q2 2026, up 9.9% from $6.06 million a year earlier and up 35.4% from the prior quarter.
Powered by 
Analysis
Lantern Pharma (LTRN) Cash & Equivalents (2019 - 2026) Analysis & Trends
At the end of FY2025, Lantern Pharma's Cash & Equivalents came in at $4.42 million, down 41.1% from FY2024.
- Annual Cash & Equivalents has declined for four consecutive years, with a five-year compound annual growth rate of -25.5% (FY2020 to FY2025).
- In prior years, Lantern Pharma's Cash & Equivalents was $7.51 million in FY2024 (-65.8%), $21.94 million in FY2023 (-41.0%), $37.2 million in FY2022 (-27.8%) and $51.52 million in FY2021 (+167.9%).
- Quarterly Cash & Equivalents has run from a low of $4.42 million in Q4 2025 to a high of $54.67 million in Q3 2021 over five years.
- On a year-over-year basis, Cash & Equivalents increased in two of the last eight quarters, with an average decline of 37.9%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q4 2021, with growth of 167.9%; the weakest was Q3 2024, with a decline of 68.3%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $4.92 million (Q1 2026), $4.42 million (Q4 2025) and $8.39 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.83 Bn | 1,078.42 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 610.61 Bn | 529.14 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 500.66 Bn | 473.77 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.64 Bn | 309.02 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 291.14 Bn | 255.13 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 254.18 Bn | 227.87 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 229.46 Bn | 184.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 190.33 Bn | 164.53 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 167.92 Bn | 114.57 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Lantern Pharma | 7.95 Mn | -28.21 Mn | - | 6.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.66 Mn |
| Mar 31, 2026 | 4.92 Mn |
| Dec 31, 2025 | 4.42 Mn |
| Sep 30, 2025 | 8.39 Mn |
| Jun 30, 2025 | 6.06 Mn |
| Mar 31, 2025 | 6.38 Mn |
| Dec 31, 2024 | 7.51 Mn |
| Sep 30, 2024 | 8.10 Mn |
| Jun 30, 2024 | 12.98 Mn |
| Mar 31, 2024 | 18.36 Mn |
| Dec 31, 2023 | 21.94 Mn |
| Sep 30, 2023 | 25.57 Mn |
| Jun 30, 2023 | 28.42 Mn |
| Mar 31, 2023 | 32.48 Mn |
| Dec 31, 2022 | 37.20 Mn |
| Sep 30, 2022 | 39.26 Mn |
| Jun 30, 2022 | 43.36 Mn |
| Mar 31, 2022 | 46.65 Mn |
| Dec 31, 2021 | 51.52 Mn |
| Sep 30, 2021 | 54.67 Mn |
API Access
Lantern Pharma Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=LTRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "LTRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=LTRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();